Where Did Psychedelics Come From? The Full Story From Evolution to Alien Theory

Psychedelics are everywhere. In fungi, in cacti, in vines, in seeds, in tree bark, in the skin of toads, and — in the case of DMT — inside your own brain.

How did they get there?

The official evolutionary explanation

The mainstream scientific answer is that psychoactive compounds are secondary metabolites — chemicals that plants and fungi produce that aren't directly involved in growth or reproduction but serve other ecological functions.

The primary proposed function: predator deterrence. Compounds that disrupt an insect's or animal's nervous system discourage it from eating the plant. The plant survives better. The compound is selected for.

This explanation is reasonable. It applies to many secondary metabolites — caffeine is toxic to insects in high concentrations, alkaloids in nightshade deter grazing animals, capsaicin in peppers deters mammals while birds (who spread the seeds) are immune.

The predator deterrent theory is the default explanation. It should be taken seriously. But it has significant gaps when applied to classical psychedelics.

Why the official explanation is incomplete

Three problems undermine the standard explanation for classical psychedelics specifically:

Problem 1: Animals seek them out. If these compounds deter predators, why do many animals actively consume them? Reindeer eat fly agaric mushrooms and appear to experience altered states. Jaguars seek out ayahuasca vine leaves. Various species deliberately consume psychoactive plants at levels consistent with intentional use, not accidental ingestion.

Problem 2: The receptor specificity. Deterrence doesn't require precision. Toxins that generally disrupt nervous systems would work. But classical psychedelics — psilocybin, mescaline, DMT, LSD — all target very specific receptor subtypes in ways that produce consistent altered consciousness rather than simple neurological disruption. That level of precision serves deterrence poorly. It serves something else excellently.

Problem 3: Convergent evolution without apparent pressure. Multiple compounds targeting the same consciousness-altering mechanism evolved independently in unrelated organisms on separate continents. The convergence implies strong selection pressure. What's selecting for human 5-HT2A agonism in a jungle vine?

The major natural psychedelics and their origins

Psilocybin — produced by over 200 fungal species across every continent. Evolved independently at least four times. Primary receptor target: 5-HT2A.

Mescaline — produced by approximately 40 cactus species in the Americas. Converged on the same 5-HT2A receptor as psilocybin, through a completely different chemical pathway, in a completely different kingdom of life.

DMT — produced by hundreds of plant species worldwide and endogenously in mammalian brains. The same molecule appears in the plant kingdom and in your brain simultaneously.

Ibogaine — from the Tabernanthe iboga shrub of Central Africa. Produces multi-day experiences; used in Bwiti initiation ceremonies and increasingly in addiction treatment.

Salvinorin A — from Salvia divinorum, a sage native to Mexico. The only known non-nitrogen-containing psychedelic. Targets kappa-opioid receptors rather than serotonin — a completely different mechanism, same category of experience.

The convergent evolution problem at scale

The psilocybin story is striking: one compound, four independent evolutions, 200+ species, every continent. But the pattern is bigger than psilocybin.

Multiple distinct psychedelic compounds, from completely different chemical families, in completely different organisms, on completely different continents, all converging on human neurochemistry. Psilocybin and mescaline both hit 5-HT2A despite being structurally different and evolved in completely different kingdoms of life. DMT is in both plants and mammalian brains — across phyla. Salvinorin A hits kappa-opioid in a completely different mechanism but produces similar experiential results.

This is not one accident. It's a pattern across the entire pharmacopeia of natural psychedelics.

DMT is produced by hundreds of plant species across every continent. It is also produced inside the human brain. The same molecule. In the plant kingdom and in the animal kingdom simultaneously. The odds of that being coincidence are worth calculating.

The receptor targeting problem

Here is the deeper anomaly: different psychedelic compounds hit different receptors, but they all produce altered states of consciousness.

5-HT2A agonism from psilocybin. 5-HT2A agonism from mescaline (structurally different compound, same target). Sigma-1 and 5-HT2A from DMT. Kappa-opioid from salvinorin A. NMDA antagonism from ketamine.

Different chemical families. Different receptor systems. Consistent output: altered consciousness.

This is not what random secondary metabolite production produces. Random metabolite production produces varied toxins with varied effects. What we have instead is convergence — from multiple angles, through multiple mechanisms — on the same category of experience.

Alternative theories

Several frameworks have been proposed:

Plant-animal coevolution: plants developed psychoactive compounds to manipulate animal behavior (spreading seeds via animals experiencing altered states). Interesting, but not well-supported by evidence.

The neurochemical hypothesis: organisms with similar neurotransmitters share receptor sensitivity, so plants producing compounds that mimic their own signaling molecules happen to match animal receptors. Plausible for some compounds, insufficient for the full picture.

Stoned Ape (McKenna): psilocybin drove human cognitive evolution. Addresses the human specificity but not the multi-compound convergence or cross-species distribution.

Psychospermia: these compounds are designed biological technologies, distributed deliberately across planetary biospheres to interface with consciousness wherever it reaches sufficient complexity.

The question of whether consciousness is the point

The question of where psychedelics came from is really the question of whether consciousness is something the universe is interested in.

The distribution of these compounds suggests it might be. They are everywhere, they are precise, and their effects converge on one outcome: expanded awareness of the nature of consciousness itself.

Random doesn't produce this pattern. Deterrence doesn't explain the precision. Something else is going on.

Visit The Map to see how these compounds fit into the full Technospermia theory, or explore The Entities for the complete field guide to every compound covered.